71 related articles for article (PubMed ID: 30301525)
21. Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia.
Kassem N; Alshurafa A; Elsabah H; El Omri H
Clin Case Rep; 2023 Nov; 11(11):e8223. PubMed ID: 38028081
[TBL] [Abstract][Full Text] [Related]
22. Cell Regulation of Proliferation and Differentiation ex vivo for Cells Containing Ph Chromosome in Chronic Myeloid Leukemia.
Grineva NI; Akhlynina TV; Gerasimova LP; Manakova TE; Sarycheva NG; Schmarov DA; Tumofeev AM; Nydenova NM; Kolosova LY; Kolosheynova TI; Kovaleva LG; Kuznetsov SV; Vorontsova AV; Turkina AG
Acta Naturae; 2009 Oct; 1(3):108-20. PubMed ID: 22649623
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive investigation of the prognostic values and molecular mechanisms of syntaxin binding protein 5 antisense RNA 1 in patients with colon adenocarcinoma based on RNA sequencing dataset.
Wei H; Tang L; Wang J; Ni M; Liao X; Guo E
J Cancer; 2023; 14(9):1607-1622. PubMed ID: 37325053
[No Abstract] [Full Text] [Related]
24. Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma.
Huang X; Wang W; Li Y
Genet Mol Biol; 2023; 46(1):e20220136. PubMed ID: 36735625
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10.
Chen W; Yang W; Zhang C; Liu T; Zhu J; Wang H; Li T; Jin A; Ding L; Xian J; Tian T; Pan B; Guo W; Wang B
Oxid Med Cell Longev; 2022; 2022():6986445. PubMed ID: 36466092
[TBL] [Abstract][Full Text] [Related]
26. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.
Manni W; Min W
MedComm (2020); 2022 Dec; 3(4):e176. PubMed ID: 36226253
[TBL] [Abstract][Full Text] [Related]
27. The Wnt/β-catenin signalling pathway in Haematological Neoplasms.
Yu S; Han R; Gan R
Biomark Res; 2022 Oct; 10(1):74. PubMed ID: 36224652
[TBL] [Abstract][Full Text] [Related]
28. Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma.
Deng T; Gong Y; Liao X; Wang X; Zhou X; Zhu G; Mo L
Front Oncol; 2021; 11():650828. PubMed ID: 34164339
[TBL] [Abstract][Full Text] [Related]
29. Analysis of differentially expressed genes responsible for the suppressive effect of anisomycin on cell proliferation of DLD-1 cells.
Ushijima H; Monzaki R; Funakoshi M
Biochem Biophys Rep; 2021 Sep; 27():101038. PubMed ID: 34151031
[TBL] [Abstract][Full Text] [Related]
30. Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Xiao Y; Tu Y; Li Y
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33792624
[TBL] [Abstract][Full Text] [Related]
31. Targeting of the Alox12-12-HETE in Blast Crisis Chronic Myeloid Leukemia Inhibits Leukemia Stem/Progenitor Cell Function.
Gao S; Hu J; Li Y
Cancer Manag Res; 2020; 12():12509-12517. PubMed ID: 33312001
[TBL] [Abstract][Full Text] [Related]
32. Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives.
Blagodatski A; Klimenko A; Jia L; Katanaev VL
Cells; 2020 Mar; 9(3):. PubMed ID: 32131438
[TBL] [Abstract][Full Text] [Related]
33. Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
Ye W; Ni Z; Yicheng S; Pan H; Huang Y; Xiong Y; Liu T
Int J Oncol; 2019 Dec; 55(6):1296-1312. PubMed ID: 31638182
[TBL] [Abstract][Full Text] [Related]
34. Morphine activates blast-phase chronic myeloid leukemia cells and alleviates the effects of tyrosine kinase inhibitors.
Zhou Z; Liu T; Zhang J
Biochem Biophys Res Commun; 2019 Dec; 520(3):560-565. PubMed ID: 31615652
[TBL] [Abstract][Full Text] [Related]
35. A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.
He B; Wang Q; Liu X; Lu Z; Han J; Pan C; Carter BZ; Liu Q; Xu N; Zhou H
Biomed Pharmacother; 2020 Sep; 129():110390. PubMed ID: 32563150
[TBL] [Abstract][Full Text] [Related]
36. Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.
Liu Z; Li Y; Lv C; Wang L; Song H
Biochem Biophys Res Commun; 2016 Sep; 478(2):893-9. PubMed ID: 27520370
[TBL] [Abstract][Full Text] [Related]
37. Characterization of cancer stem cells in chronic myeloid leukaemia.
Jørgensen HG; Holyoake TL
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1347-51. PubMed ID: 17956348
[TBL] [Abstract][Full Text] [Related]
38. [Research advance on molecular genetics of CML blast crisis].
Zhu HQ; Zhang S; Liu XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt/β-catenin signaling.
Li Y; Hu J; Song H; Wu T
Biochem Biophys Res Commun; 2018 Nov; 505(3):858-864. PubMed ID: 30301525
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
